It has been demonstrated recently that human growth hormone (HGH) increases the tubular reabsorption of phosphate in man (1, 2). This effect is probably responsible for the fall in urinary excretion of phosphate and the rise in plasma level of phosphorus produced by growth hormone (GH) and may also explain the elevation of plasma phosphorus found in acromegaly.The action of GH on tubular transport of phosphate is not necessarily a direct one. Since parathormone decreases maximal tubular reabsorption of phosphate (Tmpo4), GH might affect phosphate reabsorption by inhibiting the secretion of parathormone or by preventing its peripheral action.Indeed the first of these two hypotheses receives some support from metabolic studies: the enhancement of gastrointestinal absorption of calcium, which may occur during treatment with HGH (3), might be expected to inhibit parathyroid secretion.The present study has been undertaken to determine whether the action of GH on tubular transport of phosphate could be explained by a decrease in parathyroid secretion or in parathormone activity. For
MethodsFemale dogs fed constant diets were used for these experiments. Renal studies were performed 22 hours after the last feeding. The dogs were unanesthetized. The bladder was catheterized with a rubber catheter that remained in place throughout the experiment. Five hundred ml of water was given by stomach tube to increase urine volume. Blood was drawn from an indwelling arterial needle for control blood phosphorus and creatinine.A priming dose of creatinine and phosphate was administered intravenously (20 ml of a 10% creatinine solution, 20 ml of a solution containing Na2HPO4 12 H20, 10%, and KH2PO4, 0.75%o). A sustaining solution containing creatinine and phosphate was then infused at a rate such that a gradual increase of the plasma phosphorus value in the range of 9 to 14 mg per 100 ml was obtained, and serum creatinine value of about 50 to 70 mg per 100 ml was reached.Thirty minutes after the infusion was begun, urine was collected for consecutive periods varying in length from 10 to 15 minutes. Blood was drawn from the artery at the mid-point of each period. Each collection was ended by washing the bladder twice with distilled water and air.After five collection periods, 300 U of PTH 1 was injected intravenously.The infusion of creatinine and phosphorus was maintained, and eight further collections of urine were performed. Three days after such an experiment, intramuscular injections of bovine GH2 were given once a day (1.5 mg per kg per day) for 8 days; on day 8 of treatment, the renal study was repeated. The